PROTA THERAPEUTICS
Prota Therapeutics is an Australian, proprietary limited, privately-held biotech company established in 2016 to develop and commercialize novel combination probiotic allergen oral immunotherapy treatments. Prota holds an exclusive license to the patented probiotic food immunotherapy technology, developed at the MCRI. Series A funding of AUD $15m was secured from OneVentures, a leading Australian venture capital investment firm (OneVentures' Healthcare Fund III) – including $5M from the Austral... ian Commonwealth Government Biomedical Translation Fund – as well as private investment. This has enabled Prota to advance their clinical program, develop scalable cGMP product manufacturing processes, and initiate discussions with regulatory agencies in the lead up to a planned large-scale pivotal Phase 3 efficacy and safety study for the PRT100 peanut allergy treatment.
PROTA THERAPEUTICS
Social Links:
Industry:
Biotechnology Product Research Therapeutics
Founded:
2016-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.protatherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Mobile Non Scaleable Content Microsoft Exchange Online Amazon
Current Employees Featured
Founder
Investors List
OneVentures
OneVentures investment in Series A - Prota Therapeutics
Official Site Inspections
http://www.protatherapeutics.com Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: web2.brightspire.com.au
- IP address: 95.111.217.214
- Location: Ukraine
- Latitude: 50.4522
- Longitude: 30.5287
- Timezone: Europe/Kiev
